RAXTEMY

Pharmaceutical preparations for the treatment of asthma in patients 6 years of age and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema; Anti-inflammatories